PRTN3 and rheumatic disorder: The presence of cANCA and pANCA patients suffering from rheumatic disease was associated with higher mortality compared with reference population (respectively, HR, 3.12; 95% CI, 1.28–7.55 and HR, 2.08; 95% CI, 1.08–4.01).